Synonyms: Acelex® (S. Korea) | CG-100649 | CG100649
polmacoxib is an approved drug
Compound class:
Synthetic organic
Comment: Polmacoxib is a first-in-class dual COX2/carbonic anhydrase I/II inhibitor, a potential non-steroidal anti-inflammatory drug (NSAID) with postulated attenuated cardiovascular risk compared to selective COX2 inhibiting NSAIDs [1].
|
|
Classification | |
Compound class | Synthetic organic |
Ligand families/groups | Non-steroidal anti-inflammatory ligands |
Approved drug? | Yes |
IUPAC Name |
4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxofuran-2-yl]benzenesulfonamide |
International Nonproprietary Names | |
INN number | INN |
9898 | polmacoxib |
Synonyms |
Acelex® (S. Korea) | CG-100649 | CG100649 |
Database Links | |
CAS Registry No. | 301692-76-2 |
ChEMBL Ligand | CHEMBL166863 |
DrugCentral Ligand | 5240 |
GtoPdb PubChem SID | 252166528 |
PubChem CID | 9841854 |
RCSB PDB Ligand | 949 |
Search Google for chemical match using the InChIKey | IJWPAFMIFNSIGD-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | IJWPAFMIFNSIGD |
Search PubMed clinical trials | polmacoxib |
Search PubMed titles | polmacoxib |
Search PubMed titles/abstracts | polmacoxib |
UniChem Compound Search for chemical match using the InChIKey | IJWPAFMIFNSIGD-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | IJWPAFMIFNSIGD-UHFFFAOYSA-N |
Wikipedia | Polmacoxib |